Tan, AdrianGoodman , KirsteenWalker, AllanHudson, JemmaMacLennan, Graeme SSelby, Peter LFraser, William DRalston, Stuart HPRISM-EZ Trial Group2018-02-092018-02-092017-06Tan, A, Goodman , K, Walker, A, Hudson, J, MacLennan, G S, Selby, P L, Fraser, W D, Ralston, S H & PRISM-EZ Trial Group 2017, 'Long-Term Randomized Trial of Intensive Versus Symptomatic Management in Paget's Disease of Bone : The PRISM-EZ Study', Journal of Bone and Mineral Research, vol. 32, no. 6, pp. 1165-1173. https://doi.org/10.1002/jbmr.30660884-0431ORCID: /0000-0002-1039-5646/work/98038547http://hdl.handle.net/2164/10009The study was supported by grants from Arthritis Research UK (Ref: 42014) and the Paget’s Association (UK). The funders had no role in the study design, data collection or analysis, preparation of the manuscript or decision to publish.9148688engPaget's disease of bonebisphosphonatesquality of lifecinical trialtreatmentR MedicineGeneral MedicineArthritis Research UK (ARUK)42014RLong-Term Randomized Trial of Intensive Versus Symptomatic Management in Paget's Disease of Bone : The PRISM-EZ StudyJournal article10.1002/jbmr.3066326